Page 14 - Reflections_dyslipidaemia_newsletter4_2023
P. 14
REFLECTIONS
Dyslipidaemia
Dyslipidaemia Global Newsletter #4 2023
ACRONYMS:
ACL, adenosine triphosphate citrate lyase; ACS, acute coronary syndrome; AMI, acute myocardial infarction; ASCVD, atherosclerotic
cardiovascular disease; ATP, adenosine triphosphate; AVS, aortic venous stenosis; BMI, body mass index; BP, blood pressure;
Dyslipidaemia
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CI, confidence interval; CHD, coronary heart disease; CKD,
chronic kidney disease; CRP, C-reactive protein; CVD, cardiovascular disease; EAS, European Atherosclerosis Society; FH, familial
hypercholesterolemia; HDL-C, high-density lipoprotein; HR, hazard ratio; HRT, hormonal replacement therapy; IQR, interquartile
range; LDL-C, low-density lipoprotein; LLT, lipid-lowering therapy; Lp(a), lipoprotein(a); MACE, major adverse cardiovascular events;
MI, myocardial infarction; PCSK9i, proprotein convertase subtilisin/kexin type-9 inhibitor; PM, particulate matter; RC, remnant
cholesterol; RCTs, randomized controlled trials; RR, relative risk; siRNA, small interfering ribonucleic acid; T2DM, type 2 diabetes
mellitus; TG, triglycerides.
TABLE OF CONTENTS
